{"biological_condition":["Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturer’s protocol "],"cell_line":["C2C12 (myoblasts)"],"identifier":["29618024","EXP051559","GSE69527","GSM1702886"],"jaspar_id":["MA0500.2"],"prediction_models":["DAMO"],"tf_id":"EXP051559.C2C12_myoblasts.MYOG","tf_name":"MYOG","tfbs":[{"DAMO":[{"adj_centrimo_pvalue":0.0,"distance_threshold":"22.5","jaspar_id":"MA0500","jaspar_version":"2","score_threshold":"88.2","total_tfbs":"2660","model_detail":"","bed_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP051559.C2C12_myoblasts.MYOG/EXP051559.C2C12_myoblasts.MYOG.MA0500.2.damo.bed","fasta_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP051559.C2C12_myoblasts.MYOG/EXP051559.C2C12_myoblasts.MYOG.MA0500.2.damo.fa","summary_plot_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP051559.C2C12_myoblasts.MYOG/EXP051559.C2C12_myoblasts.MYOG.MA0500.2.damo.png"}]}],"total_peaks":"11482"}